GHK-Cu vs Copper Tripeptide
GHK-Cu and 'copper tripeptide' are the same molecule: a glycyl-L-histidyl-L-lysine tripeptide bound to a copper-2 ion. The terminology overlap confuses newcomers. The meaningful research question isn't which molecule — it's topical vs injectable delivery, because the two routes produce very different biological profiles.
They're the same molecule under two different names. The actual research choice is about delivery format — topical (cosmetic cream at 1-3% concentration) vs injectable GHK-Cu (SubQ, 1-2 mg). Topical is the default for skin research; injectable is the default for systemic tissue research.
Contender A
GHK-Cu (injectable)
Also: GHK-Cu SubQ
Glycyl-L-histidyl-L-lysine tripeptide chelated to Cu2+ — drives collagen synthesis, angiogenesis, and antioxidant enzyme upregulation systemically via SubQ delivery.
- Half-life
- ~2-4 hours
- Primary use
- Systemic tissue / hair / wound research
- Dose range
- 1-2 mg SubQ, 2-3x weekly
- Cost tier
- $$ · Moderate sourcing cost
Contender B
Copper Tripeptide (topical)
Also: GHK-Cu cream
Same GHK-Cu molecule applied topically — acts locally on skin fibroblasts to stimulate collagen and elastin without meaningful systemic absorption.
- Half-life
- Local-acting (limited systemic uptake)
- Primary use
- Skin / scalp / anti-aging cosmetic research
- Dose range
- 1-3% topical formulation, daily
- Cost tier
- $ · Low sourcing cost
Detailed Comparison
10 attributes side-by-side. Highlighted rows show where one tool has a clear structural edge.
| Attribute | GHK-Cu SubQ | GHK-Cu cream | Edge |
|---|---|---|---|
Molecule | GHK-Cu | GHK-Cu (identical) | Tie |
Delivery route | SubQ injection | Topical cream / serum | Tie |
Systemic effect | Yes | Minimal | GHK-Cu SubQ |
Skin / cosmetic research | Moderate | Strong, direct | GHK-Cu cream |
Hair / scalp research | Scalp injections viable | Topical scalp serum standard | GHK-Cu cream |
Wound-healing research | Systemic support | Direct local application | Tie |
Evidence maturity | Expert practitioner data | Decades of cosmetic-industry data | GHK-Cu cream |
Cost / accessibility | Moderate, needs reconstitution | Low, OTC cosmetic formulations | GHK-Cu cream |
Protocol complexity | Injection protocol | Daily topical | GHK-Cu cream |
Safety profile | Clean at research doses | Very clean | GHK-Cu cream |
Practitioner Notes
Sourced from practitioner-validated protocols — not PubMed abstracts.
The naming overlap produces the most common newcomer mistake in this category. 'Copper peptides' in a cosmetics catalog and 'GHK-Cu' in a peptide catalog are the same active molecule. The difference that matters for research is delivery — and the two routes answer different research questions.
Topical is the better tool for any research question about skin directly: photodamage, wound-healing models, scalp research, anti-aging endpoints. The local concentration at the fibroblast is higher than what a systemic SubQ dose can achieve at the skin surface, and decades of cosmetic-industry data (Skin Biology, Neova, and practitioner formulations) give this route a more mature evidence base than the injectable version for skin endpoints.
Injectable GHK-Cu is the better tool for systemic research questions: tissue repair where the relevant tissue isn't skin, angiogenesis research, systemic antioxidant-enzyme studies. Protocols in the corpus running SubQ GHK-Cu for skin alone are a resource-inefficient use of the molecule — topical is cheaper and delivers higher local concentration.
One practitioner nuance: scalp protocols sometimes pair both. Topical minoxidil-adjacent GHK-Cu serum plus intermittent scalp injections target the hair follicle from two angles.
Stacking & Switching
Can these be combined? Should you switch from one to the other? Titration considerations.
Stack compatibility: See the “Stacks well” or “Stack compatibility” row in the comparison table above. When the edge column shows Tie, both compounds run together cleanly. When one compound dominates, check the protocol notes for the specific stacking pattern practitioners use.
Switching protocol: The general pattern across practitioner protocols: hold the current dose stable, introduce the new compound at its lowest titration step, run both for a 1-2 week cross-over window, then taper the original. Abrupt switches produce rebound effects as the original compound's steady state clears.
Half-life math: DoseCraft's PK-aware AI models half-life decay and stack overlap across every pairing above. The 20x20 interaction matrix flags contraindications automatically — no manual math, no overlapping-signal blindspots.
Frequently Asked Questions
Indexed for SERP FAQPage rich results.
Is GHK-Cu the same as copper peptide?
+
Yes. GHK-Cu is the research-nomenclature name; 'copper tripeptide' or 'copper peptide' is the cosmetic-industry name. Same molecule — glycyl-L-histidyl-L-lysine bound to Cu2+.
Is topical as effective as injectable?
+
For skin-specific research, topical is usually more effective because local concentration at skin fibroblasts is higher. For systemic tissue research, injectable is necessary because topical doesn't reach deeper tissues.
Can I combine both routes?
+
Yes. Practitioners running skin + systemic research often use topical for scalp/face and SubQ for systemic tissue research. The overall copper load at research doses is well within safe margins.
Why does it turn blue?
+
The Cu2+ ion. Copper coordinated to peptide backbones produces a characteristic blue-to-teal color. Reconstituted GHK-Cu should be clear-to-blue; a pink tint suggests oxidation and reduced potency.
Is there a safety concern with copper?
+
At research doses, no. Both routes deliver copper loads well below dietary intake. Research subjects with Wilson's disease or copper-metabolism disorders would avoid this tool, but general-population research protocols show clean safety.
Related Comparisons
Healing
BPC-157 vs TB-500
BPC-157 is a pentadecapeptide derived from gastric juice with strong localized healing signals, especially in GI and tendon research. TB-500 is a fragment of Thymosin Beta-4 with systemic actin-binding activity driving cell migration, angiogenesis, and broad tissue recovery. Half-lives and delivery profiles are very different; so are their niches.
ReadLongevity
Epitalon vs Thymalin
Epitalon (also called Epithalon) is a synthetic tetrapeptide developed from pineal-gland extract. Thymalin is a polypeptide complex from thymus tissue. Both emerged from the Khavinson longevity research program in Soviet/Russian gerontology. Different organ sources, different mechanisms — pineal / circadian for Epitalon, thymic / immune for Thymalin.
ReadLongevity
MOTS-c vs SS-31
MOTS-c is a mitochondrial-derived peptide that signals systemically — it activates AMPK, improves insulin sensitivity, and enhances exercise capacity. SS-31 (elamipretide) is a mitochondrial-targeting peptide that binds cardiolipin on the inner mitochondrial membrane, preserving electron-transport-chain function and reducing oxidative damage. Same organelle, completely different mechanism.
ReadTrack Your Protocol with PK-Aware AI
Compound choice is step one. DoseCraft models half-life decay, stack overlap, and titration paths across 90+ peptides — a pharmacokinetic reasoning layer on top of practitioner-validated protocols.
Track your protocol with PK-aware AI in DoseCraftResearch-only disclaimer: This comparison is for research and educational purposes only. Peptides referenced are sold for research use by third-party suppliers. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Always consult a licensed physician before acting on any peptide protocol information.